Xilingio M 10mg/5mg/1000mg Tablet ER
Xilingio M 10mg/5mg/1000mg Tablet ER
Empagliflozin (10mg) + Linagliptin (5mg) + Metformin (1000mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Xilingio M 10mg/5mg/1000mg Tablet ER: Comprehensive Management of Type 2 Diabetes
Xilingio M 10mg/5mg/1000mg Tablet ER is a once-daily extended-release tablet containing a carefully balanced combination of empagliflozin, linagliptin, and metformin. This multi-targeted approach provides comprehensive management for patients with Type 2 diabetes, targeting multiple key mechanisms to optimize blood sugar control:
* Empagliflozin (10mg): An SGLT2 inhibitor that lowers blood glucose levels by promoting the excretion of glucose through the kidneys.
* Linagliptin (5mg): A dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases incretin hormone levels to enhance insulin secretion and reduce glucagon release.
* Metformin (1000mg): A first-line medication for Type 2 diabetes that reduces hepatic glucose production and enhances insulin sensitivity.
Xilingio M offers the convenience of once daily administration, allowing patients to simplify their treatment regimen. This product is indicated for adults with Type 2 Diabetes who require additional blood sugar control measures.
Disclaimer: Consult your healthcare professional before starting any new medication.
Active composition
Empagliflozin 10 mg
+2 more active ingredients
About Empagliflozin
Empagliflozin is used to treat Type 2 diabetes. It works by inhibiting glucose reabsorption in the kidneys, promoting glucose excretion. Empagliflozin is effective in managing blood sugar levels. In summary, it plays a vital role in diabetes management.
How It Works
Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the renal proximal tubules, reducing glucose reabsorption and increasing urinary glucose excretion.
All Active Ingredients
Linagliptin
Linagliptin inhibits the enzyme DPP-4, leading to increased levels of incretin hormones, which promote insulin secretion and inhibit glucagon release, thereby lowering blood glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Xilingio M 10mg/5mg/1000mg Tablet ER